An English woman is in mesothelioma remission two years after being diagnosed and given merely six to nine months to live. The secret to her newfound longevity has been a cutting-edge mesothelioma treatment developed in Germany at the University Clinic in Frankfurt. The woman, 49-year-old Debbie Brewer, contracted mesothelioma after a childhood of hugging her father when he came home from work covered in asbestos dust. She filed a lawsuit and won a six-figure award in the case. Given only six to nine months to live by her British doctors, she chose to use her lawsuit winnings to pursue treatment techniques that were still in the experimental stages. Her search took her to the University Clinic in Frankfurt. There she opted to try their experimental mesothelioma treatments as her last resort for survival. Foregoing traditional chemotherapy, Brewer agreed to the chemoembolisation technique used by the University Clinic.
This method is most often used when treating liver cancer and it involves injecting the chemotherapy drugs directly into the tumor through a catheter tube. For Brewer’s cancer, the drugs were injected into the tumor in the tissues around her lungs. The treatment appears to be successful, as Brewer has been informed that her tumor is half its original size and is not expected to return. Physicians at the University Clinic gave her the good news that her cancer is in remission. Thanks to the treatment, Brewer can watch her children: Siobhan, 22, Richard, 19, and Kieran, 11, grow into adulthood, and she might even get to hold her grandchildren. Others using the technique in the German study found success 60 percent of the time. Brewer now wants to use her newly extended life to campaign to bring the treatment to the United Kingdom to undergo trials in hopes of seeing it reach mainstream medicine in the near future.